Kevin A. David

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

Andrew M. Evens, Kevin A. David, Irene Helenowski et al. · Journal of Clinical Oncology · 2010 · 314 citations · Full text

Solid Organ Transplantation, Immunology, Surgery +17

Low Incidence of Perioperative Chemotherapy for Stage III Bladder Cancer 1998 to 2003: A Report From the National Cancer Data Base

Kevin A. David, Matthew I. Milowsky, Jamie Ritchey et al. · The Journal of Urology · 2007 · 245 citations

Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial

Catherine Diefenbach, Fangxin Hong, Richard F. Ambinder et al. · The Lancet Haematology · 2020 · 137 citations · Full text

Phase 1/2, Lymphoid Neoplasia, Oncology +10

Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh et al. · Blood · 2021 · 122 citations · Full text

Mitochondrial-Mediated Apoptosis in Lymphoma Cells by the Diterpenoid Lactone Andrographolide, the Active Component of <i>Andrographis paniculata</i>

Shuo Yang, Andrew M. Evens, Sheila Prachand et al. · Clinical Cancer Research · 2010 · 97 citations · Full text